RPAM
IART icon

Rhenman & Partners Asset Management’s Integra LifeSciences IART Stock Holding History

Rhenman & Partners Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-110,091
Closed -$2.15M – 94
2013
Q4 		$2.15M Buy
+110,091
New +$2.02M 0.84% 53

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Rhenman & Partners Asset Management's IART Position: Q1 2014 in Review

Rhenman & Partners Asset Management sold out of Integra LifeSciences (IART) in Q1 2014, closing a stake of 110,091 shares — an estimated $2.15M sold.

Rhenman & Partners Asset Management first reported a position in IART in Q4 2013 and held it in 1 quarter. The position peaked at $2.15M in Q4 2013. 144 funds tracked by Wall St. Rank hold IART as of Q1 2014.

  • Rhenman & Partners Asset Management reported no remaining Integra LifeSciences position as of Q1 2014 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 110,091 Integra LifeSciences shares in Q1 2014, an estimated $2.15M.
  • Rhenman & Partners Asset Management first reported a position in Integra LifeSciences in Q4 2013 and held it in 1 quarter.
  • Rhenman & Partners Asset Management's Integra LifeSciences position peaked at $2.15M in Q4 2013.
  • 144 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2014.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2014, filed 14 May 2014.